Barclays Maintains Overweight on Geron, Lowers Price Target to $4
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Peter Lawson maintains Geron (NASDAQ:GERN) with a Overweight and lowers the price target from $9 to $4.
Barclays analyst Peter Lawson maintains Geron (NASDAQ:GERN) with a Overweight and lowers the price target from $9 to $4.